Zeo ScientifiX (ZEOX) Profit After Tax Growth (3y) (2015 - 2026)
Zeo ScientifiX (ZEOX) Profit After Tax Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 6.30% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.23% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 71.02% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 17.25% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.89% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 37.44% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -29.12% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 59.34% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -38.56% |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 58.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 58.24% |
| Jan 31, 2026 | 28.05% |
| Oct 31, 2025 | 35.37% |
| Jul 31, 2025 | 8.75% |
| Apr 30, 2025 | 1.51% |
| Jan 31, 2025 | 9.80% |
| Oct 31, 2024 | -9.38% |
| Jul 31, 2024 | 10.44% |
| Apr 30, 2024 | 14.52% |
| Jan 31, 2024 | 49.65% |
| Oct 31, 2023 | 40.44% |
| Jul 31, 2023 | 32.49% |
| Apr 30, 2023 | -10.82% |
| Jan 31, 2023 | -48.64% |
| Oct 31, 2022 | -61.03% |
| Jul 31, 2022 | -98.20% |
| Apr 30, 2022 | -51.26% |
| Jan 31, 2022 | -90.71% |
| Oct 31, 2021 | -28.01% |
| Jul 31, 2021 | -66.13% |